Amylin Pharmaceuticals, Inc.: SWOT Analysis & Company Profile

Additional Information

Key Highlights

Amylin Pharmaceuticals, Inc. (Amylin) is an US based biopharmaceutical company engages in the development and marketing of innovative medicines for the treatment of diabetes, obesity and other diseases. It markets two medicines namely, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection to treat diabetes. Through a network of wholesale distributors, Amylin sells its products to healthcare providers, managed healthcare organizations, wholesalers and pharmacies, government purchasers and other third-party players. Amylin also entered into strategic agreement and collaboration with various companies such as Alkermes, Inc., Biocon Limited, Eli Lilly and Company, Psylin Neurosciences, Inc., and Takeda Pharmaceutical Company Limited develop novel treatments for the patients. The company is headquartered in California, the US.

Keywords

Amylin Pharmaceuticals, Inc. Company Overview, Amylin Pharmaceuticals, Inc. Key Facts, Amylin Pharmaceuticals, Inc. Business Description, Amylin Pharmaceuticals, Inc. Major Products and Services, Amylin Pharmaceuticals, Inc. History, Amylin Pharmaceuticals, Inc. SWOT Analysis, Amylin Pharmaceuticals, Inc. Strengths, Amylin Pharmaceuticals, Inc. Weaknesses, Amylin Pharmaceuticals, Inc. Opportunities, Amylin Pharmaceuticals, Inc. Threats, Amylin Pharmaceuticals, Inc. Key Competitors, Amylin Pharmaceuticals, Inc. Key Employees, Amylin Pharmaceuticals, Inc. Key Employee Biographies, Amylin Pharmaceuticals, Inc. Company Statement, Amylin Pharmaceuticals, Inc. Locations and Subsidiaries, Amylin Pharmaceuticals, Inc. Financial Ratios, Amylin Pharmaceuticals, Inc. Capital Market Ratios, Amylin Pharmaceuticals, Inc. Annual Ratios, Amylin Pharmaceuticals, Inc. Interim Ratios, Amylin Pharmaceuticals, Inc. Ratio Charts, Amylin Pharmaceuticals, Inc. Share Data

Companies Mentioned

Amylin Pharmaceuticals, Inc.